Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bile duct cancer, Biliary tree cancers, Bowel (colorectal) cancer, Cancer of unknown primary (CUP), Colon cancer, Gallbladder cancer, Liver cancer, Oesophageal cancer, Pancreatic cancer, Rectal cancer, Small bowel cancer, Stomach cancer
Closed
Phase 2
This study is comparing the 2 chemotherapy drugs capecitabine (Xeloda) and Teysuno.
Recruitment start: 3 February 2014
Recruitment end: 30 April 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sally Clive
Cancer Research UK
Edinburgh Cancer Research Centre
Experimental Cancer Medicine Centre (ECMC)
KIS fund for colorectal cancer research
NHS Lothian
NIHR Clinical Research Network: Cancer
Nordic Pharma group
Scottish Cancer Research Network
University of Edinburgh
Last reviewed: 9 October 2023
CRUK internal database number: 11419
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
